Alibaba Investors Face October 5 Deadline in Securities Class Action

The lawsuit, filed in the United States District Court for the Southern District of New York, centers on claims that Alibaba failed to disclose risks associated with its classification as a "Chinese military company" under the National Defense Authorization Act for fiscal year 2025. Plaintiffs contend that the company’s required operating licenses from the Chinese Ministry of Industry and Information Technology placed it under this designation, a fact they allege was omitted from public disclosures. Shares saw a significant decline, falling from a period high of $173.68 on October 9, 2025, to $95.07 by June 25, 2026, representing a 45% drop.

Beyond regulatory concerns, the action addresses claims involving Alibaba’s artificial intelligence lab. Reports indicated that operators linked to the company’s Qwen AI model allegedly used nearly 25,000 fraudulent accounts to access Anthropic PBC’s Claude model. This practice, described as adversarial distillation, purportedly targeted sensitive software engineering capabilities. The firm Levi & Korsinsky, LLP, which is representing the shareholders, argues that these undisclosed operational failures and regulatory exposures left investors vulnerable to market risks that were not adequately priced into the company's American Depositary Shares.